Bharath Biotech’s Covaxine and SII’s Covishield are competing. The Bharath Biotech’s Covaxine is a lesser cost than Covishield. The Hyderabad Pharmaceutical company will be signing the final contract with the government soon. Deciding the cost is taking time since the government is trying to negotiate the best possible price. According to the sources, Bharath Biotech has been trying to have their price competitive lower than the near competitor.